60 Results for "

Crotalaria candicans Wight & Arn.

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "Crotalaria candicans Wight & Arn." in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-16060
CAS No.: 956104-40-8
Synonyms: ARN-509
Target:  

Androgen Receptor

Research Areas:  

Cancer

Apalutamide (ARN-509) is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM .
9
9 Cited Publications
Cat. No.: HY-18204A
CAS No.: 936623-90-4
Synonyms: LCZ696
Sacubitril/Valsartan (LCZ696), comprised Valsartan and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-acting angiotensin receptor-neprilysin (ARN) inhibitor for hypertension and heart failure . Sacubitril/Valsartan ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis .
6
6 Cited Publications
Cat. No.: HY-12864
CAS No.: 1365888-06-7
Purity:  99.85%
Synonyms: ARN-810; GDC-0810
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Brilanestrant (ARN-810; GDC-0810) is an orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM.
4
4 Cited Publications
Cat. No.: HY-120856
CAS No.: 1613710-01-2
Purity:  99.66%
ARN-3236 is an oral active and selective inhibitor of salt-inducible kinase 2 (SIK2), with IC50s of <1 nM, 21.63 nM and 6.63 nM for SIK2, SIK1 and SIK3, respectively. Has anti-cancer activity .
2
2 Cited Publications
Cat. No.: HY-N1735
CAS No.: 1156-78-1
2′-Hydroxygenistein is a natural product that can be isolated from Crotalaria pallida and C. assamica. 2′-Hydroxygenistein shows anti-inflammatory activity. 2′-Hydroxygenistein shows significant concentration-dependent inhibitory effects on the release of β-glucuronidase and lysozyme from rat neutrophils, with IC50 values of 5.9 ± 1.4 and 9.7 ± 3.5 μM, respectively .
1
1 Cited Publications
Cat. No.: HY-103691A
CAS No.: 1700693-96-4
Purity:  99.54%
Target:  

Autophagy Apoptosis

Research Areas:  

Cancer

ARN5187 trihydrochloride is a lysosomotropic REV-ERBβ ligand with a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. ARN5187 trihydrochloride shows lysosomotropic potency and cytotoxicity. ARN5187 trihydrochloride induces apoptosis .
Cat. No.: HY-145339
CAS No.: 1971937-18-4
Purity:  99.80%
Target:  

Ceramidase

ARN19702 is a selective, orally active, reversible, and brain-penetrant N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 230 nM for human NAAA. ARN19702 has pain relief effects .
Cat. No.: HY-103592
CAS No.: 1644158-57-5
Purity:  99.29%
Target:  

Ceramidase

Research Areas:  

Cancer

ARN14974, a benzoxazolone carboxamide, is a potent and systemically active inhibitors of intracellular acid ceramidase (IC50=79 nM) .
Cat. No.: HY-N5037
CAS No.: 109008-27-7
Ilexoside D is isolated from the roots of Ilex pubescens Hook. et Arn. Ilexoside D has the anti-tissue factor activity as well as the antithrombotic activity .
Cat. No.: HY-137466
CAS No.: 2230854-93-8
Purity:  98.08%
Target:  

Topoisomerase

Research Areas:  

Cancer

ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β. ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM). ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research .
Cat. No.: HY-115498
CAS No.: 1037837-27-6
Purity:  99.08%
ARN14494 is a potent and selective serine palmitoyltransferase (SPT) inhibitor, with an IC50 of 27.3 nM. ARN14494 affects the CNS in terms of anti-inflammation and neuroprotection. ARN14494 protects neurons from β-amyloid 1-42-induced neurotoxicity through a variety of mechanisms, including anti-oxidation, anti-apoptosis, and anti-inflammation. ARN14494 can be used for Alzheimer’s disease research .
Cat. No.: HY-120813
CAS No.: 1373625-34-3
Purity:  98.83%
Synonyms: URB913
Target:  

Ceramidase

Research Areas:  

Inflammation/Immunology

ARN 077 is a potent and selective N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 7 nM for human NAAA . ARN 077 significantly increases palmitoyl ethanolamine (PEA) levels within the CNS and has broad antinociceptive activity in mice and rats .
Cat. No.: HY-18292
CAS No.: 102212-26-0
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

ARN2966 is a potent, orally active and cross the blood-brain barrier amyloid precursor protein (APP) translation modulator.
Cat. No.: HY-144290
CAS No.: 2649882-80-2
Purity:  99.66%
Target:  

GSK-3 DYRK

Research Areas:  

Neurological Disease

ARN25068 is a sub-micromolar inhibitor of the three protein kinases, GSK-3β, FYN and DYRK1A to tackle tau hyperphosphorylation .
Cat. No.: HY-163171
CAS No.: 1214569-31-9
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

ARN 11391 is a selective enhancer of inositol triphosphate receptor type 1 (ITPR1). ARN 11391 can be used in the study of spinocerebellar ataxia .
Cat. No.: HY-150514
CAS No.: 1381459-14-8
Purity:  99.34%
Target:  

Prion Protein

Research Areas:  

Infection

ARN1468 (compound 5) is an orally active and potent SerpinA3n inhibitor. ARN1468 can inhibit serpins activity would set the protease free to further reduce prion accumulation. ARN1468 shows anti-prion effect in ScGT1 RML, ScGT1 22L, ScN2a RML, and ScN2a 22L cell lines, with EC50 values of 8.64, 19.3, 11.2, and 6.27 μM .
Cat. No.: HY-120813A
CAS No.: 1439366-88-7
Purity:  99.71%
Synonyms: URB913 (enantiomer)
Target:  

Drug Isomer

Research Areas:  

Inflammation/Immunology

ARN 077 enantiomer (19) is the less active enantiomer of ARN 077, with an IC50 of 3.53 μM for rat NAAA .
Cat. No.: HY-124597
CAS No.: 1628343-77-0
Purity:  95.00%
Target:  

Ceramidase

Research Areas:  

Inflammation/Immunology

ARN726 is a potent NAAA (N-acylethanolamine acid amidase) inhibitor with an IC50 of 0.073 µM. ARN726 decreases alcohol self-administration in a dose-dependent manner .
Cat. No.: HY-110101
CAS No.: 488793-85-7
Purity:  98.36%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

ARN272 is an anandamide transport inhibitor .
Cat. No.: HY-149464
CAS No.: 2248691-29-2
Purity:  98.73%
Target:  

Ras

Research Areas:  

Cancer

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model .